Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human erythropoietin in anemic cancer patients undergoing chemotherapy
NCT00144482Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Dec 2003
- Primary completion
- Mar 2005
01
Overview
A Phase 3 trial of erythropoietin in Chemotherapy-induced anemia (CIA), sponsored by Chugai Pharmaceutical Co., Ltd.. Started Dec 2003; status: completed.
02
Drugs
erythropoietin
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT00144482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144482.